Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method

被引:30
作者
Choo, KS
Kim, IW
Jung, JK
Suh, YG
Chung, SJ
Lee, MH
Shim, CK
机构
[1] Seoul Natl Univ, Coll Pharm, Dept Pharmaceut, Kwanak Gu, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Dept Pharmaceut Mfg Chem, Kwanak Gu, Seoul 151742, South Korea
关键词
HPLC-UV detection; simultaneous determination; loxoprofen; alcohol metabolites; human plasma and urine;
D O I
10.1016/S0731-7085(00)00583-5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, reliable HPLC-UV detection method was developed for the simultaneous determination of loxoprofen and its metabolites (i.e. trans- and cis-alcohol metabolites), in human plasma and urine samples. The method involves the addition of a ketoprofen (internal standard) solution in methanol, zinc sulfate solution and acetonitrile to plasma and urine samples, followed by centrifugation. An aliquot of the supernatant was evaporated to dryness, and the residue reconstituted in a mobile phase (acetonitrile:water = 35:65 v/v, pH 3.0). An aliquot of the solution was then directly injected into the HPLC system. Separations were performed on octadecylsilica column (250 x 4.5 mm, 5 mum) with a guard column (3.2 x 1.5 cm, 7 mum) at ambient temperature. Loxoprofen and the metabolites in the eluent were monitored at 220 nm (a.u.f.s. 0.005). Coefficients of variations (CV%) and recoveries for loxoprofen and its metabolites were below 10 and over 96%, respectively, in the 200 similar to 15 000 ng ml(-1) range for plasma and 500 - 50 000 ng ml(-1) range for urine. Calibration curves for ail the compounds in the plasma and urine were linear over the above-mentioned concentration ranges with a common correlation coefficient of 0.999. The detection limit of the present method was 100 ng for all the compounds. These results indicate that the present method is very simple and readily applicable to routine bioavailability studies of these compounds with an acceptable sensitivity. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:639 / 650
页数:12
相关论文
共 10 条
[1]  
ABE S, 1985, JPN J INFLAMMATION, V5, P67
[2]  
IRAI TH, 1997, J CHROMATOGR-BIOMED, V692, P375
[3]  
KIM SJ, 1997, KOR J CLIN PHARM, V7, P73
[4]   INHIBITION OF PROSTAGLANDIN SYNTHESIS BY SODIUM 2-[4-(2-OXOCYCLOPENTYLMETHYL)PHENYL] PROPIONATE DIHYDRATE (CS-600), A NEW ANTI-INFLAMMATORY DRUG, AND ITS ACTIVE METABOLITE INVITRO AND INVIVO [J].
MATSUDA, K ;
TANAKA, Y ;
USHIYAMA, S ;
OHNISHI, K ;
YAMAZAKI, M .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (15) :2473-2478
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF LOXOPROFEN AND ITS DIASTEREOMERIC ALCOHOL METABOLITES IN BIOLOGICAL-FLUIDS BY FLUORESCENCE LABELING WITH 4-BROMOMETHYL-6,7-METHYLENEDIOXYCOUMARIN [J].
NAGANUMA, H ;
KAWAHARA, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 530 (02) :387-396
[6]  
NAGASHIMA H, 1984, CHEM PHARM BULL, V32, P251
[7]  
NARUTO S, 1984, CHEM PHARM BULL, V32, P258
[8]   INHIBITION OF PROSTAGLANDIN PRODUCTION IN THE INFLAMMATORY TISSUE BY LOXOPROFEN-NA, AN ANTIINFLAMMATORY PRODRUG [J].
SUGIMOTO, M ;
KOJIMA, T ;
ASAMI, M ;
IIZUKA, Y ;
MATSUDA, K .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (12) :2363-2368
[9]  
TANAKA Y, 1983, CHEM PHARM BULL, V31, P3656
[10]   SYNTHESIS AND ANTIINFLAMMATORY ACTIVITY OF [(CYCLOALKYLMETHYL)PHENYL]ACETIC ACIDS AND RELATED-COMPOUNDS [J].
TERADA, A ;
NARUTO, S ;
WACHI, K ;
TANAKA, S ;
IIZUKA, Y ;
MISAKA, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (02) :212-216